TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
85,967
|
82,169
|
86,621 |
| Financial expenses |
814
|
1,363
|
1,205 |
| Earnings before taxes |
-4,770
|
-27,353
|
-16,914 |
| EBITDA |
6,155
|
-18,204
|
-9,659 |
| Total assets |
109,611
|
109,707
|
139,058 |
| Current assets |
54,222
|
46,532
|
47,454 |
| Current liabilities |
24,918
|
53,938
|
47,550 |
| Equity capital |
80,730
|
50,684
|
90,407 |
| - share capital |
97
|
101
|
100 |
| Employees (average) |
53
|
69
|
75 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
73.7%
|
46.2%
|
65.0% |
| Turnover per employee |
1,622
|
1,191
|
1,155 |
| Profit as a percentage of turnover |
-5.5%
|
-33.3%
|
-19.5% |
| Return on assets (ROA) |
-3.6%
|
-23.7%
|
-11.3% |
| Current ratio |
217.6%
|
86.3%
|
99.8% |
| Return on equity (ROE) |
-5.9%
|
-54.0%
|
-18.7% |
| Change turnover |
6,515
|
-4,898
|
-744 |
| Change turnover % |
8%
|
-6% | |
| Chg. No. of employees |
-16
|
-6
|
9 |
| Chg. No. of employees % |
-23%
|
-8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.